Narmada Gelatines Ltd Valuation Shift Signals Renewed Price Attractiveness

Valuation Metrics Reflect Renewed Investor Interest

The company’s current price-to-earnings (P/E) ratio stands at 9.74, a figure that remains comfortably below the peer average of approximately 27.5, signalling a relatively undervalued status within the specialty chemicals sector. This P/E multiple is a key driver behind the upgrade in valuation grade from very attractive to attractive, indicating that while the stock is no longer at its cheapest historical levels, it still offers significant value compared to industry benchmarks.

Complementing the P/E ratio, the price-to-book value (P/BV) ratio of 2.13 further supports the stock’s attractive valuation stance. This metric suggests that investors are paying just over twice the company’s net asset value, a reasonable premium given Narmada Gelatines’ strong return on capital employed (ROCE) of 20.86% and return on equity (ROE) of 19.40%. These returns highlight efficient capital utilisation and profitability, justifying the current valuation multiples.

Comparative Analysis with Industry Peers

When placed alongside its competitors, Narmada Gelatines’ valuation appears particularly compelling. For instance, Sanstar and Stallion India trade at P/E ratios of 55.47 and 46.87 respectively, while Titan Biotech’s P/E ratio is an elevated 71.78. Even the more moderately priced Nitta Gelatin commands a P/E of 14.64, significantly higher than Narmada’s 9.74. This disparity underscores the relative affordability of Narmada Gelatines’ shares, especially given its robust financial health and growth prospects.

Enterprise value to EBITDA (EV/EBITDA) multiples also favour Narmada Gelatines, with a ratio of 7.93 compared to peers like Sanstar at 47.00 and Stallion India at 28.59. Such a low EV/EBITDA multiple indicates that the company is trading at a discount to its earnings before interest, taxes, depreciation and amortisation, further enhancing its attractiveness to value-focused investors.

Strong Financial Performance Underpins Valuation

Narmada Gelatines’ financial metrics reinforce the valuation upgrade. The company’s PEG ratio of 0.26 is notably low, suggesting that its price is not only reasonable relative to earnings but also favourable when growth expectations are factored in. This contrasts sharply with peers such as Titan Biotech, whose PEG ratio stands at 3.43, indicating a more expensive valuation relative to growth.

Dividend yield at 2.27% adds an income component to the investment case, appealing to investors seeking steady returns alongside capital appreciation. The company’s enterprise value to capital employed ratio of 2.03 and EV to sales ratio of 1.37 further highlight efficient asset utilisation and revenue generation, supporting the current valuation framework.

Market Performance Outpaces Benchmarks

Market returns for Narmada Gelatines have been impressive, significantly outstripping the broader Sensex index across multiple time horizons. Over the past week, the stock surged 13.63% compared to Sensex’s modest 1.56% gain. On a one-month basis, Narmada Gelatines delivered a 13.50% return while the Sensex declined by 0.23%. Year-to-date, the stock has appreciated 27.34%, contrasting with the Sensex’s 10.25% loss.

Longer-term performance is equally compelling, with a five-year return of 145.64% versus the Sensex’s 51.05%, and a ten-year return of 205.56% closely outpacing the benchmark’s 195.54%. These figures illustrate the company’s consistent ability to generate shareholder value and justify the recent upgrade in its valuation grade and Mojo rating.

Mojo Score and Grade Upgrade Reflect Growing Confidence

MarketsMOJO’s proprietary Mojo Score for Narmada Gelatines has risen to 84.0, accompanied by an upgrade in Mojo Grade from Buy to Strong Buy as of 25 May 2026. This upgrade reflects enhanced confidence in the company’s fundamentals, valuation, and growth outlook. The micro-cap classification underscores the stock’s potential for significant upside, albeit with higher volatility compared to larger peers.

The valuation grade improvement from very attractive to attractive signals a recalibration of price expectations, suggesting that while the stock has appreciated, it remains a compelling investment opportunity relative to its intrinsic value and sector peers.

Price Action and Trading Range Insights

On 26 May 2026, Narmada Gelatines closed at ₹439.70, up 9.41% from the previous close of ₹401.90. The stock touched a high of ₹460.00 during the day, matching its 52-week high, while the 52-week low stands at ₹327.30. This price action indicates strong buying interest and momentum, with the stock nearing its annual peak, signalling positive market sentiment.

Such price strength, combined with attractive valuation metrics, suggests that investors are increasingly recognising the company’s growth potential and financial resilience.

Sector Outlook and Peer Comparison

The specialty chemicals sector remains competitive, with several companies trading at elevated valuations. Narmada Gelatines’ attractive multiples relative to peers such as Sanstar, Stallion India, and Titan Biotech highlight its relative value proposition. While some peers command premium valuations due to scale or niche positioning, Narmada’s efficient capital utilisation and consistent returns provide a solid foundation for sustained growth.

Investors seeking exposure to the specialty chemicals space with a focus on value and quality may find Narmada Gelatines’ current valuation and financial profile particularly appealing.

Investment Considerations and Outlook

While Narmada Gelatines’ valuation upgrade and strong financial metrics present a compelling investment case, prospective investors should consider the inherent risks associated with micro-cap stocks, including liquidity constraints and sector cyclicality. However, the company’s consistent outperformance relative to the Sensex and peers, combined with a strong return profile and reasonable valuation multiples, suggest a favourable risk-reward balance.

Given the current market dynamics and the company’s upgraded Mojo Grade of Strong Buy, Narmada Gelatines appears well-positioned to capitalise on growth opportunities within the specialty chemicals sector. Investors seeking quality exposure with attractive valuation parameters may find this stock a worthy addition to their portfolios.

Summary

Narmada Gelatines Ltd’s recent valuation upgrade from very attractive to attractive is underpinned by a low P/E ratio of 9.74, a reasonable P/BV of 2.13, and robust profitability metrics including a ROCE of 20.86% and ROE of 19.40%. The company’s EV/EBITDA multiple of 7.93 compares favourably against expensive peers, reinforcing its relative value. Market returns have significantly outpaced the Sensex across multiple time frames, reflecting strong investor sentiment. The Mojo Score upgrade to 84.0 and Strong Buy rating further validate the stock’s appeal. While micro-cap risks remain, the overall outlook for Narmada Gelatines is positive, making it an attractive proposition for value-conscious investors in the specialty chemicals sector.

Only Rs. 20,999 - Get MojoOne + Stock of the Week for 3 Years Get 71% Off →